MC gliosis, a hallmark of AD‐related pathology, involves generalized and potentially protective responses, such as elevated glial fibrillary acidic protein (GFAP) and diminished glutamine synthetase (GS) levels (Bringmann et al. 2006). This evidence concerns the gene GLUL and Alzheimer disease.